Description: This session takes a fresh look at the issues related to acute care focus and the challenges of providing coordinated care for chronic conditions in the United States and internationally. From the Record of the Society of Actuaries, Vol. 31, No. 2, Session 67

Description: Discussion of how to mature value-based contracts between health insurers and provider organizations to improve population health and financial sustainability. Centers around contract parameter consistency, revenue predictability and risk assessment. Intended audience are health plan and ACO actuaries and leaders. Authors are writing from the provider perspective in value-based contracts.

Description: Panelist discuss lifestyle issues and their effects on medical costs, both for managing costs and for making decisions about plan design. Topics include employer responses, lifestyle-based profiling, and obesity. From the Record of the Society of Actuaries, Vol. 31 No. 2, Session 27

Description: The presenters will explore the roles of mental health and social determinants of health in the management of a population's total health. We will explore how emerging sources of data and information have led to a renewed focus on managing mental health conditions and social determinants of health. Speakers will address current health care programs that utilize this data and information to manage the total care for populations using predictive models to improve the deployment of resources and initiatives to improve the cost of care and health of populations. The presenters will also look at how providers of care are approaching mental health co-morbidities to manage physical health and social determinants of health in the management of patients.

Description: This is article identifies and quantifies how one of several prospective cures for chronic conditions will impact healthcare.

Description: Panelists discuss issues related to special programs used to treat members with known chronic conditions. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: The coming wave of biosimilars could dramatically affect prescription drug costs and benefit strategies over the next several years. The launch of many Humira biosimilars in 2023 is the Big Event that will largely determine the impact of the biosimilar wave. Payers have many decisions to make about coverage and formulary tiers. What factors will drive payer decision-making?

Description: Attendees will learn about new and emerging techniques for optimizing health care utilization from the highest users of health care. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 129

Description: This is the abstract to the paper, How the Current System Fails People With Chronic Illnesses by Reinhard Priester, Robert L. Kane, Annette M. Totten.

Description: This session discussion is about high cost claimants in medical benefit plans and how to control costs and anti-selection. From Record of the Society of Actuaries Vol. 15, No. 3B.